Medicare Enrolled
Dr. Slobodan Miric, M.D.
Neurology · Denville, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Miric from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Miric?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Miric
Dr. Slobodan Miric is a neurology specialist in Denville, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Miric performed 1,078 Medicare services across 737 unique beneficiaries.
Between the years covered by Open Payments, Dr. Miric received a total of $35,969 from 64 pharmaceutical and/or device companies across 685 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Miric is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 34% volume in NJ
$35,969 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,078
Medicare services
Top 34% in NJ for neurology
737
Unique beneficiaries
$132
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~57 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
450 | $107 | $434 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
72 | $89 | $357 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
70 | $141 | $563 |
| Complete ultrasound of brain blood flow An ultrasound test that evaluates blood flow within the brain's blood vessels. It uses sound waves to create images of the vessels and assess circulation. |
59 | $199 | $991 |
| Ultrasound of brain blood flow An ultrasound test used to examine blood flow within the brain to check for blood clots. |
58 | $150 | $1,153 |
| Ultrasound of brain blood flow following medication An ultrasound test used to assess blood flow within the brain after a medication has been administered. |
55 | $204 | $1,009 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
51 | $143 | $702 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
47 | $73 | $308 |
| Neuropsychological test evaluation, first hour A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process. |
42 | $111 | $434 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
41 | $356 | $1,393 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
33 | $52 | $202 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 26 | $68 | $267 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
25 | $221 | $877 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
20 | $189 | $755 |
| Placement of skin electrodes and measurement of stimulated sites in arms Skin electrodes are placed on the arms to measure the response to stimulation at specific sites. |
18 | $162 | $800 |
| Drug test with direct observation A drug screening test performed under direct observation to ensure the sample is provided correctly. This method is used to verify the integrity of the specimen collection process. |
11 | $12 | $50 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$35,969
Total received (2018-2024)
Avg $5,138/year across 7 years
Top 11% in NJ for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
64
Companies
685
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$27,402 (76.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,567 (23.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,101
2023
$1,229
2022
$9,727
2021
$6,429
2020
$13,352
2019
$2,218
2018
$913
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
EMD Serono, Inc.
$712
ABBVIE INC.
$482
PFIZER INC.
$195
E.R. Squibb & Sons, L.L.C.
$125
Lilly USA, LLC
$121
ARGENX US, INC.
$90
Takeda Pharmaceuticals U.S.A., Inc.
$52
UCB, Inc.
$36
Celgene Corporation
$32
Neurocrine Biosciences, Inc.
$32
Kyowa Kirin, Inc.
$31
Supernus Pharmaceuticals, Inc.
$29
CSL Behring
$24
Grifols USA, LLC
$18
Harmony Biosciences Llc
$17
Otsuka America Pharmaceutical, Inc.
$17
Eisai Inc.
$17
SK Life Science, Inc.
$16
Novartis Pharmaceuticals Corporation
$15
Teva Pharmaceuticals USA, Inc.
$15
SCILEX PHARMACEUTICALS INC.
$14
Amneal Pharmaceuticals LLC
$13
Top 3 companies account for 66.1% of 2024 payments
All-time payments by company (2018-2024) ›
Allergan, Inc.
$12,927
Biohaven Pharmaceutical Holding Company Ltd.
$7,250
AbbVie Inc.
$4,932
ABBVIE INC.
$2,028
EMD Serono, Inc.
$1,436
Supernus Pharmaceuticals, Inc.
$1,342
Novartis Pharmaceuticals Corporation
$737
Teva Pharmaceuticals USA, Inc.
$667
Lilly USA, LLC
$590
Amgen Inc.
$368
SK Life Science, Inc.
$347
E.R. Squibb & Sons, L.L.C.
$321
CSL Behring
$303
Biogen, Inc.
$246
Biohaven Pharmaceuticals, Inc.
$228
PFIZER INC.
$219
Acorda Therapeutics, Inc
$150
UCB, Inc.
$127
Eisai Inc.
$123
ARGENX US, INC.
$121
Avanir Pharmaceuticals, Inc.
$97
Alexion Pharmaceuticals, Inc.
$70
Mallinckrodt Enterprises LLC
$68
Sunovion Pharmaceuticals Inc.
$68
Celgene Corporation
$61
Lundbeck LLC
$57
Almatica Pharma LLC
$57
Genentech USA, Inc.
$57
Amneal Pharmaceuticals LLC
$55
ACADIA Pharmaceuticals Inc
$55
Endo Pharmaceuticals Inc.
$54
ARBOR PHARMACEUTICALS, INC.
$52
Takeda Pharmaceuticals U.S.A., Inc.
$52
GE HealthCare
$48
Kyowa Kirin, Inc.
$47
Neurocrine Biosciences, Inc.
$46
Mallinckrodt LLC
$43
Collegium Pharmaceutical, Inc.
$39
Grifols USA, LLC
$33
IDORSIA PHARMACEUTICALS US INC
$31
Arbor Pharmaceuticals, Inc.
$28
Zyla Life Sciences
$27
SCILEX PHARMACEUTICALS INC.
$26
Janssen Pharmaceuticals, Inc
$26
Neurelis, Inc.
$25
Bayer HealthCare Pharmaceuticals Inc.
$25
Adamas Pharmaceuticals, Inc.
$24
Harmony Biosciences Llc
$17
IMPEL PHARMACEUTICALS INC.
$17
Otsuka America Pharmaceutical, Inc.
$17
ANI Pharmaceuticals, Inc.
$16
Exeltis, USA Inc.
$15
GENZYME CORPORATION
$15
Axsome Therapeutics, Inc.
$14
Allergan Inc.
$14
Jazz Pharmaceuticals Inc.
$13
Currax Pharmaceuticals LLC
$12
JAZZ PHARMACEUTICALS INC.
$12
Merck Sharp & Dohme Corporation
$12
GE Healthcare
$12
Kowa Pharmaceuticals America, Inc.
$12
Bausch Health US, LLC
$12
Harmony Biosciences LLC
$11
Shire North American Group Inc
$11
Top 3 companies account for 69.8% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AIMOVIG · AJOVY · AMPYRA · AMYVID · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · Belbuca · Betaseron · Briviact · CONTRAVE · ELYXYB - CELECOXIB · ELYXYB - celecoxib · EMGALITY · ENTRESTO · Fycompa · GILENYA · GOCOVRI · GRALISE · Gamunex-C · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · KISUNLA · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · Mavenclad · NAPRELAN · NASCOBAL · NORTHERA · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · Nuedexta · OCREVUS · OXTELLAR XR · Ongentys · PLEGRIDY · PURIFIED CORTROPHIN GEL · Ponvory · Privigen · QELBREE · QULIPTA · QUVIVIQ · Qelbree · REXULTI · RYTARY · SOLIRIS · SPRIX · Seglentis · Soliris · Sunosi · TECFIDERA · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · VALTOCO · VUMERITY · VYEPTI · VYVANSE · VYVGART · VYVGART HYTRULO · WAKIX · Wakix · XCOPRI · XYREM · Xtampza ER · Xyrem · ZEPOSIA · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (76%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
Neurologists within 10 mi
260
Per 100K population
50.9
County median income
$134,929
Nearest hospital
SAINT CLARE'S HOSPITAL/ DENVILLE CAMPUS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Miric is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 11% of NJ peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Miric experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Miric performed 450 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Miric receive payments from pharmaceutical companies?
Yes. Dr. Miric received a total of $35,969 from 64 companies across 685 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Miric's costs compare to other neurologists in Denville?
Dr. Miric's average Medicare payment per service is $132. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Miric) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Denville
Browse neurologists in Denville ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NJ
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NJ
Which NJ neurologists receive the most from drug and device companies.
By company
Allergan, Inc. Payments to Doctors
See all physicians who received payments from Allergan, Inc.
By company
Biohaven Pharmaceutical Holding Company Ltd. Payments to Doctors
See all physicians who received payments from Biohaven Pharmaceutical Holding Company Ltd.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology